ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 91 filers reported holding ADMA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 4.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,798 | +12.7% | 40,447 | +16.2% | 0.00% | – |
| Q2 2023 | $128,457 | +5.8% | 34,813 | -5.1% | 0.00% | – |
| Q1 2023 | $121,366 | -12.6% | 36,667 | +2.1% | 0.00% | – |
| Q4 2022 | $138,880 | +59.6% | 35,926 | 0.0% | 0.00% | – |
| Q3 2022 | $87,000 | +29.9% | 35,926 | +5.9% | 0.00% | – |
| Q2 2022 | $67,000 | +644.4% | 33,926 | +543.0% | 0.00% | – |
| Q1 2022 | $9,000 | +50.0% | 5,276 | +23.4% | 0.00% | – |
| Q4 2021 | $6,000 | -57.1% | 4,276 | -65.4% | 0.00% | – |
| Q3 2021 | $14,000 | -39.1% | 12,374 | -10.8% | 0.00% | – |
| Q2 2021 | $23,000 | -45.2% | 13,874 | -42.8% | 0.00% | – |
| Q1 2021 | $42,000 | -51.2% | 24,240 | -45.2% | 0.00% | – |
| Q4 2020 | $86,000 | +4.9% | 44,194 | +28.3% | 0.00% | – |
| Q3 2020 | $82,000 | +446.7% | 34,435 | +588.7% | 0.00% | – |
| Q2 2020 | $15,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |